| Autor: |
Giles DA; Holtom-Garrett Program in Neuroimmunology, Department of Neurology.; Graduate Program in Immunology, and.; Medical Scientist Training Program, University of Michigan, Ann Arbor, Michigan, USA., Duncker PC; Holtom-Garrett Program in Neuroimmunology, Department of Neurology.; Graduate Program in Immunology, and., Wilkinson NM; Holtom-Garrett Program in Neuroimmunology, Department of Neurology., Washnock-Schmid JM; Holtom-Garrett Program in Neuroimmunology, Department of Neurology., Segal BM; Holtom-Garrett Program in Neuroimmunology, Department of Neurology.; Graduate Program in Immunology, and.; Neurology Service, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA. |
| Abstrakt: |
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease of the central nervous system (CNS), induced by the adoptive transfer of myelin-reactive CD4+ T cells into naive syngeneic mice. It is widely used as a rodent model of multiple sclerosis (MS). The development of EAE lesions is initiated when transferred CD4+ T cells access the CNS and are reactivated by local antigen-presenting cells (APCs) bearing endogenous myelin peptide/MHC class II complexes. The identity of the CNS-resident, lesion-initiating APCs is widely debated. Here we demonstrate that classical dendritic cells (cDCs) normally reside in the meninges, brain, and spinal cord in the steady state. These cells are unique among candidate CNS APCs in their ability to stimulate naive, as well as effector, myelin-specific T cells to proliferate and produce proinflammatory cytokines directly ex vivo. cDCs expanded in the meninges and CNS parenchyma in association with disease progression. Selective depletion of cDCs led to a decrease in the number of myelin-primed donor T cells in the CNS and reduced the incidence of clinical EAE by half. Based on our findings, we propose that cDCs, and the factors that regulate them, be further investigated as potential therapeutic targets in MS. |
